Advanced systemic mastocytosis (advSM) is a rare and serious form of systemic mastocytosis, a blood disorder that involves the overproduction of mast cells. Mast cells are a type of white blood cell ...

—In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants progressed to an advanced form of SM, incurring greater healthcare costs along the way.

KUTV — Imagine living in constant fear of the unknown, where each day brings the possibility of unpredictable and potentially debilitating symptoms that threaten to derail your life. This is the ...

Please provide your email address to receive an email when new articles are posted on . "Ayvakit is the first and only medicine approved by the FDA to treat indolent systemic mastocytosis, marking a ...

Jill Zinsmeyer came to Austin for love, but Austin didn't love her. Living in Napa Valley, Calif., before the move, Zinsmeyer hadn't come into contact with such things as fire ants and the small ...

In the complex world of rare diseases, even small advances in understanding can make a profound difference in patients’ lives. Medscape Live is bringing back-to-back educational programs to San Diego ...

HT-KIT demonstrates significant tumor downregulation and over 80% reduction in KIT expression in preclinical models of GIST and systemic mastocytosis. The therapy targets KIT gene expression at the ...

Systemic mastocytosis is a myeloid neoplasm divided into six subcategories by the recent classification by WHO. It involves the accumulation of abnormal mast cells (MCs) in the skin, liver, spleen, ...